Skip to main content

Effects of Lateral Pharma compounds in COPD, Asthma, COVID models and in vitro experiments

Project Member(s): Hansbro, P.

Funding or Partner Organisation: Lateral Pharma Pty Ltd
Lateral Pharma Pty Ltd

Start year: 2021

Summary: Lateral Pharma want to test their peptides in our mouse models of lung inflammation

FOR Codes: Cardiovascular medicine and haematology, Respiratory System and Diseases (incl. Asthma), Infectious Diseases, Cardiorespiratory Medicine and Haematology, Clinical health